Showing results (301-310 of 432) with videos related to

Sort By:
Pageof 44
Neurology|November 5, 2010
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest oldT M Polvikoski, E C W van Straaten, F Barkhof, et al.
Multiple Sclerosis and Related Disorders|April 17, 2015
Effect of prior treatment status and reasons for discontinuation on the efficacy and safety of fingolimod vs. interferon β-1a intramuscular: Subgroup analyses of the Trial Assessing Injectable Interferon vs. Fingolimod Oral in Relapsing-Remitting Multiple Sclerosis (TRANSFORMS)B O Khatri, J Pelletier, L Kappos, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 10, 2008
Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosisI J van den Elskamp, J Lembcke, V Dattola, et al.
Current Medical Research and Opinion|August 5, 2008
Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE studyC Ballard, M Sauter, P Scheltens, et al.
Annals of Neurology|March 20, 1998
Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosisP D Molyneux, M Filippi, F Barkhof, et al.
Neurology|April 10, 2002
Seasonal variation in immune measurements and MRI markers of disease activity in MSJ Killestein, M H G Rep, J F Meilof, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|November 25, 2005
Hippocampal atrophy on MRI in frontotemporal lobar degeneration and Alzheimer's diseaseL A van de Pol, A Hensel, W M van der Flier, et al.
AJNR. American Journal of Neuroradiology|February 15, 2008
Segmentation of subtraction images for the measurement of lesion change in multiple sclerosisY Duan, P G Hildenbrand, M P Sampat, et al.
AJNR. American Journal of Neuroradiology|August 11, 2022
Amyloid-Related Imaging Abnormalities with Emerging Alzheimer Disease Therapeutics: Detection and Reporting Recommendations for Clinical PracticeP M Cogswell, J A Barakos, F Barkhof, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patientsJ W Stroomer, J C Roos, M Sproll, et al.
Pageof 44